NEWS AND EVENTS
Stay up to date on our current affairs.
Mitsubishi Tanabe Pharma Canada Announces Canadian Authorization of RADICAVA™ (edaravone) to Treat ALS
New Country Manager Brings Significant Business Leadership And Healthcare Expertise to Mitsubishi Tanabe Pharma Canada, Inc.
Health Canada Accepts Mitsubishi Tanabe Pharma Corporation’s NDS Filing for Edaravone to Treat ALS, Grants Priority Review